Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

1.2K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

592
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
592
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

322
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
322
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

1.2K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.2K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

327
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
327

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robotic Liver Resection for Intrahepatic Cholangiocarcinoma: Perioperative and Oncologic Outcomes From a Single-Institution Experience.

The American surgeon·2026
Same author

A Review on Artificial Intelligence as a Solution to Burnout in Interventional Radiology.

Cardiovascular and interventional radiology·2026
Same author

Robotic surgical management of gallbladder cancer: comparing outcomes and feasibility of hepatectomy with or without bile duct resection and reconstruction.

Updates in surgery·2026
Same author

The benefit of mineralocorticoid receptor blockade in the treatment of experimental autoimmune encephalomyelitis mice.

The Journal of steroid biochemistry and molecular biology·2025
Same author

Artificial Intelligence-Enhanced Electrocardiography for Complete Heart Block Risk Stratification.

JAMA cardiology·2025
Same author

The Selective Glucocorticoid Receptor Modulator Cort125329 Decreases Neuroinflammation and Gliosis and Enhances Myelination in the Wobbler Model of Amyotrophic Lateral Sclerosis.

Molecular neurobiology·2025

Related Experiment Video

Updated: Nov 24, 2025

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions
10:32

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions

Published on: January 18, 2016

14.5K

Progress in progestin-based therapies for neurological disorders.

Regine Sitruk-Ware1, Brooke Bonsack2, Roberta Brinton3

  • 1Population Council, New York, NY, USA.

Neuroscience and Biobehavioral Reviews
|December 28, 2020
PubMed
Summary

Nestorone, a progestin, shows promise as a neuroprotective agent for central nervous system (CNS) disorders like multiple sclerosis. Research suggests it offers neurogenetic, remyelinating, and anti-inflammatory benefits for conditions involving demyelination and inflammation.

Keywords:
Amyotrophic lateral sclerosisMultiple sclerosisNestoroneProgesteroneSpinal cord injuryStroke

More Related Videos

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.9K
Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice
08:25

Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice

Published on: July 16, 2014

11.1K

Related Experiment Videos

Last Updated: Nov 24, 2025

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions
10:32

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions

Published on: January 18, 2016

14.5K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.9K
Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice
08:25

Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice

Published on: July 16, 2014

11.1K

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Pharmacology

Background:

  • Hormone therapy, particularly progesterone and progestins, is an emerging area in regenerative medicine for central nervous system (CNS) disorders.
  • Progesterone's initial clinical trial for traumatic brain injury failed, shifting focus to Nestorone, a progestin with potent and selective progesterone receptor activation.
  • Nestorone demonstrates significant neurogenetic, remyelinating, and anti-inflammatory effects at low doses.

Purpose of the Study:

  • To review scientific and clinical advancements in using progesterone, progestins, and Nestorone as neuroprotective agents.
  • To evaluate Nestorone's potential for treating CNS disorders such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), spinal cord injury (SCI), and stroke.
  • To provide recommendations for optimizing Nestorone's clinical application, including dosage, timing, administration route, and patient selection.

Main Methods:

  • Comprehensive review of decades of research on progesterone and progestins in neuroprotection.
  • Analysis of Nestorone's pharmacological profile, including its selective transactivation of progesterone receptors.
  • Assessment of pathological pathways in CNS disorders (demyelination, cell death, inflammation) relevant to Nestorone's effects.

Main Results:

  • Nestorone exhibits potent neurogenetic, remyelinating, and anti-inflammatory properties.
  • Its efficacy is linked to its ability to selectively target progesterone receptors.
  • The drug is a promising candidate for CNS disorders characterized by demyelination, cell death, and inflammation.

Conclusions:

  • Nestorone is a promising neuroprotective agent for multiple sclerosis, ALS, SCI, and stroke.
  • Optimizing treatment parameters (timing, dosage, route) and identifying specific patient populations are crucial for clinical advancement.
  • Further research and clinical trials are warranted to translate Nestorone's therapeutic potential into effective treatments for CNS disorders.